Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 04/30/2025 | 01/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -64.26% | 16.14% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -64.26% | 16.14% | |||
| Cost of Revenue | -29.34% | -33.78% | |||
| Gross Profit | -76.50% | 57.83% | |||
| SG&A Expenses | 15.34% | -19.02% | |||
| Depreciation & Amortization | -- | 56.44% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.03% | -15.94% | |||
| Operating Income | -264.66% | 67.32% | |||
| Income Before Tax | -280.69% | 74.61% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -280.69% | 74.61% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -280.69% | 74.61% | |||
| EBIT | -264.66% | 67.32% | |||
| EBITDA | -2,040.00% | 106.93% | |||
| EPS Basic | -300.00% | 76.47% | |||
| Normalized Basic EPS | -233.33% | 70.00% | |||
| EPS Diluted | -300.00% | 76.47% | |||
| Normalized Diluted EPS | -233.33% | 70.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||